Effects of Oral L-Carnitine Supplementation on Lipid Profile, Anemia, and Quality of Life in Chronic Renal Disease Patients under Hemodialysis: A Randomized, Double-Blinded, Placebo-Controlled Trial

Table 5

Comparison of the changes between scores of quality of life and its physical and mental subscales between two groups.

	Carnitine	Placebo	𝑃
	𝑛=24	𝑛=27
Total SF-36	0.2±12.1	−2.6±7.7	0.152
Physical subscales	−4.1±11.7	8.5±2.1	0.241
Mental subscales	2.1±10.1	−4.6±6.1	0.002